151 related articles for article (PubMed ID: 20509158)
1. First-trimester placental growth factor as a marker for hypertensive disorders and SGA.
Cowans NJ; Stamatopoulou A; Matwejew E; von Kaisenberg CS; Spencer K
Prenat Diagn; 2010 Jun; 30(6):565-70. PubMed ID: 20509158
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates.
Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
Fetal Diagn Ther; 2014; 35(4):249-57. PubMed ID: 24642536
[TBL] [Abstract][Full Text] [Related]
3. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
[TBL] [Abstract][Full Text] [Related]
4. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
[TBL] [Abstract][Full Text] [Related]
6. Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes.
Stamatopoulou A; Cowans NJ; Matwejew E; von Kaisenberg C; Spencer K
Hypertens Pregnancy; 2011; 30(4):384-95. PubMed ID: 20701472
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks' gestation in normal and pathological pregnancies.
Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
Fetal Diagn Ther; 2014; 36(2):106-16. PubMed ID: 24457972
[TBL] [Abstract][Full Text] [Related]
8. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19-24 weeks.
Poon LC; Lesmes C; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):437-45. PubMed ID: 25988293
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum placental growth factor and fetal SGA in pregnancy complicated by type 1 diabetes mellitus.
Gutaj P; Wender-Ożegowska E; Iciek R; Zawiejska A; Pietryga M; Brązert J
J Perinat Med; 2014 Sep; 42(5):629-33. PubMed ID: 24519713
[TBL] [Abstract][Full Text] [Related]
10. Early prediction of preeclampsia and small-for-gestational-age via multi-marker model in Chinese pregnancies: a prospective screening study.
Zhang J; Han L; Li W; Chen Q; Lei J; Long M; Yang W; Li W; Zeng L; Zeng S
BMC Pregnancy Childbirth; 2019 Aug; 19(1):304. PubMed ID: 31426761
[TBL] [Abstract][Full Text] [Related]
11. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
[TBL] [Abstract][Full Text] [Related]
12. Association of adiponectin and placental growth factor in amniotic fluid with second trimester fetal growth.
Kalampokas E; Vrachnis N; Samoli E; Rizos D; Iliodromiti Z; Sifakis S; Kalampokas T; Vitoratos N; Creatsas G; Botsis D
In Vivo; 2012; 26(2):327-33. PubMed ID: 22351679
[TBL] [Abstract][Full Text] [Related]
13. Prediction of small-for-gestational-age neonates: screening by maternal serum biochemical markers at 19-24 weeks.
Lesmes C; Gallo DM; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Sep; 46(3):341-9. PubMed ID: 25969963
[TBL] [Abstract][Full Text] [Related]
14. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
[TBL] [Abstract][Full Text] [Related]
17. Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders.
Engels T; Pape J; Schoofs K; Henrich W; Verlohren S
Hypertens Pregnancy; 2013 Nov; 32(4):459-73. PubMed ID: 23957293
[TBL] [Abstract][Full Text] [Related]
18. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
Bersinger NA; Ødegård RA
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
[TBL] [Abstract][Full Text] [Related]
19. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.
Cowans NJ; Spencer K; Meiri H
Prenat Diagn; 2008 Feb; 28(2):121-5. PubMed ID: 18186153
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy.
Gullai N; Stenczer B; Molvarec A; Fügedi G; Veresh Z; Nagy B; Rigó J
Hypertens Res; 2013 May; 36(5):457-62. PubMed ID: 23324863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
